Past PTSD > 5 y patients show an intermediate state, with IGF-1 (3–45 nmol/mL) approaching control levels and coping scores (Problem-Focused: 9–21/32; Emotion-Focused: 16–28/48) improving but remaining below controls, reflecting partial recovery over time. The gene discussed is IGF1; the disease is post-traumatic stress disorder.